ŠÓ°ÉAPP

Performance & Impact

Hangaia te ā mua

Create the future

UniServices is the largest R&D company of its kind in Australasia. Weā€™ve invested in over 75 companies and licensed more than 540 patent families. Weā€™ve also delivered great community impact.
iStock 1341631834

Hangaia te ā mua

Create the future

UniServices is the largest R&D company of its kind in Australasia. Weā€™ve invested in over 75 companies and licensed more than 540 patent families. Weā€™ve also delivered great community impact.

UniServices by the Numbers

8

new companies launched in 2023

27

technologies licensed in 2023

$41m

ā€“ Fair value of the University of ŠÓ°ÉAPPInventorsā€™ Fund at the end of 2023

28,592

Covid-19 vaccinator course completions through IMAC since 2021

36,659

ā€“ Clinical queries answered on IMACā€™s 0800 IMMUNE phone line in 2023

6,755

people engaging with online courses through Whāraurau in 2023

5,366

people attending training and workshop courses through Whāraurau in 2023

3,900

educators received professional training and development through Tui Tuia | Learning Circle in 2023

4,700

MRI scans performed by CAMRI in 2023

4000+

ā€“ Clinical staff in 20 hospitals trained in acute care simulations designed by NetworkZ in the past 8 years

up down

2022 Highlights

Research Impact

Understanding dementia

ŠÓ°ÉAPPresearchers working with American researchers published the groundbreaking finding that . The study followed 1.7 million New Zealanders for 30 years. Another team led by Dr Makarena Dudley embarked on a $1.1 million, three-year study to .

Prime Ministerā€™s Science Prize

A team led by Distinguished Professor Dame Jane Harding has been nationally honoured for work on . The Neonatal Glucose Studies Teamā€™s finding that sugar gel rubbed inside a babyā€™s cheek improves low blood-sugar levels has become a first-line treatment around the world.

 

Improving geothermal energy

Geothermal energy has a green reputation ā€“ but itā€™s not zero-carbon because it releases naturally occurring underground gases. With $6 million in funding, a team at the Universityā€™s Geothermal Institute aims to turn greenhouses gases into rock, permanently trapping it underground. The technology could be applied to other industries too.

Reviving mīmiro

Researchers led by Professor Anthony Hoete of the School of Architecture and Planning are and testing its seismic resilience. The mīmiro technique gave wharenui and other buildings remarkable structural stability, but with perhaps only one remaining whare in Aotearoa built with the method, the knowledge is endangered.

Community Impact

Supporting Covid-19 vaccination

The (IMAC) plays a significant role in educating the countryā€™s immunisation workforce. More than 5000 IMAC courses were completed by vaccinators across the motu in 2023. IMAC also advised healthcare staff through its 0800 phone line,  answering more than 36,000 calls during the year. IMAC also provided expert advice to the government, and responded to continuous media queries. 

Understanding whānau experiences

is the largest longitudinal study following the lives of more than 6,000 children, including some 1,200 tamariki Māori, since their pregnant mothers volunteered for the study in 2009. It offers evidence and insights into child and youth health and wellbeing in New Zealand for policymakers, researchers, community advocates, and other stakeholders.

Investment Impact

Better optical communications

Quantifi Photonics, a University of ŠÓ°ÉAPPspin-out, manufactures equipment for photonics testing and measurement in areas such as optical communications. It in Series C funding to accelerate the development of test solutions for datacom and telecom equipment manufacturers. It also , giving it research and manufacturing facilities in Thailand.

Diagnosing gut disorders

Alimetry is an ŠÓ°ÉAPPbased MedTech company that develops advanced wearable medical solutions that improve gastrointestinal care. Founded in 2019, based on a decade of groundbreaking science and engineering out of Waipapa Taumata Rau, the University of Auckland, Alimetry is striving to develop solutions that are more effective, easier on patients, and more efficient for healthcare providers. In 2022, Alimetry received FDA approval in the US for its flagship Gastric Alimetry device, a non-invasive tool to diagnose disorders of the upper gut, and has raised $16.3 million in Series A funding. 

Annual Review Mockup SkyBlue v2

Check out our 2022 annual review

Learn what we achieved in advancing and investing in research and delivering services and projects with community impact. 

Download PDF